tiprankstipranks
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Mineralys Therapeutics, Inc. (MLYS) Similar Stocks

Compare
286 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mineralys Therapeutics, Inc.
$9.14
$455.50M
-40.36%
6 Buy
0 Hold
0 Sell
Strong Buy
Ardelyx
$5.08
$1.28B
-42.61%
4 Buy
2 Hold
0 Sell
Moderate Buy
Amphastar Pharmaceuticals
$27.52
$1.37B
9.28
-39.10%
2 Buy
3 Hold
0 Sell
Moderate Buy
Rocket Pharmaceuticals
$9.45
$1.01B
-69.05%
14 Buy
1 Hold
0 Sell
Strong Buy
Kiniksa Pharmaceuticals
$20.28
$1.47B
0.45%
4 Buy
0 Hold
0 Sell
Strong Buy
Kezar Life Sciences
$5.71
$41.68M
-44.56%
2 Buy
1 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
MLYS
Mineralys Therapeutics, Inc.
8.94
-6.05
-40.36%
ARDX
Ardelyx
5.36
-3.68
-40.71%
AMPH
Amphastar Pharmaceuticals
28.43
-18.25
-39.10%
RCKT
Rocket Pharmaceuticals
9.45
-19.26
-67.08%
KNSA
Kiniksa Pharmaceuticals
20.28
0.09
0.45%
KZR
Kezar Life Sciences
5.71
-4.49
-44.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis